PMFA
AMED

Plante Moran Financial Advisors’s Amedisys AMED Stock Holding History

Plante Moran Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-42
Closed -$6K – 996
2021
Q3 		$6K Buy
+42
New +$8.73K ﹤0.01% 752

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Plante Moran Financial Advisors's AMED Position: Q4 2021 in Review

Plante Moran Financial Advisors sold out of Amedisys (AMED) in Q4 2021, closing a stake of 42 shares — an estimated $6K sold.

Plante Moran Financial Advisors first reported a position in AMED in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Plante Moran Financial Advisors reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 42 Amedisys shares in Q4 2021, an estimated $6K.
  • Plante Moran Financial Advisors first reported a position in Amedisys in Q3 2021 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Amedisys position peaked at $6K in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.